High intratumoral plasma cells content in primary prostate cancer defines a subset of tumors with potential susceptibility to immune-based treatments is a research paper published in Prostate Cancer and Prostatic Diseases (2022). On theSindex it has a DataRank of 0. It has been cited 8 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: RSG-21-023-01-TBG
U.S. Department of Defense
Grant: W81XWH-15-1-0661
U.S. Department of Health & Human Services | National Institutes of Health
Grant: 5U01CA196390
NCI NIH HHS
Grant: U01 CA196390
NLM NIH HHS
Grant: R01 LM013236
National Institutes of Health
Grant: 1R01LM013236-01A1
Generalizable biomedical informatics strategies for predictive modeling of treatment response
National Institutes of Health
Grant: 1U01CA196390-01
Multidiciplinary Integrative Genomic Approach to Distinguish Lethal from Indolent Prostate Cancer in Men of Europena and African Ancestry
Prostate Cancer Foundation
Fields of Study
MeSH Terms
Keywords